Approval · Notice of Compliance 1815 · 1999
GEN-FENOFIBRATE MICRO: Notice of Compliance 1815
Issued May 26, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1815
- Date
- May 26, 1999
- Company
- Genpharm Inc.Etobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Lipid metabolism regulator
- Canadian reference product
- LIPIDIL MICRO
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GEN-FENOFIBRATE MICRO | 02240210 | Cancelled Post Market |
Medicinal ingredients
- FENOFIBRATE 200 MG per CAP